Stock Quote
Abbott Laboratories (ABT.N) (New York Stock Exchange)
$53.64
20 Nov 2009
+1.28%
$52.96
$53.10
3,136,300
$53.74
$52.84
$57.39
$41.27
0.22
5,558,387
ABT.N
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| White, Miles | Chairman of the Board, Chief Executive Officer | 28,335,500 |
| Freyman, Thomas | Chief Financial Officer, Executive Vice President - Finance | 6,847,840 |
| Tyree, James | President of Abbott Biotech Ventures Inc | 6,232,210 |
Profile
Abbott Laboratories is engaged in the discovery, development, manufacture, and sale of a range of health care products. It has four segments: Pharmaceutical Products, Nutritional Products, Diagnostic Products, and Vascular Products. The Pharmaceutical Products segment’s products include a line of... Full Description
Company Address
Abbott Laboratories
100 Abbott Park Road
Abbott Park IL 60064
P: +1847.9376100
F: +1847.9371511
100 Abbott Park Road
Abbott Park IL 60064
P: +1847.9376100
F: +1847.9371511
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| Johnson & Johnson | $62.31 | +0.37 |
| Pfizer Inc. | $18.36 | +0.25 |
| GlaxoSmithKline plc | £1,253.50 | +13.00 |
| ABT.N | Industry | |
|---|---|---|
| P/E(TTM) | 14.91 | 3.57 |
| P/S(TTM) | 2.77 | 0.57 |
| ROI(TTM) | 16.11 | 1.86 |
| ROE(TTM) | 27.52 | 2.51 |
| Consensus Recommendation | Outperform |
|---|---|
| EPS Est. (Current Period) | 0.86 |
| EPS Est. (Current Year) | 3.71 |
| Total Revenue | $7,761.34M |
| Net Income | $1,480.37M |
| EPS | $0.95 |
